Epicentre, Médecins Sans Frontières, 8 rue Saint Sabin, Paris, France.
Trop Med Int Health. 2010 Nov;15(11):1375-81. doi: 10.1111/j.1365-3156.2010.02622.x. Epub 2010 Sep 25.
To describe the frequency of diagnosis of cryptococcosis among HIV-infected patients in Phnom Penh, Cambodia, at programme entry, to investigate associated risk factors, and to determine the incidence of cryptococcal meningitis.
We analysed individual monitoring data from 11,970 HIV-infected adults enrolled between 1999 and 2008. We used Kaplan-Meier naïve methods to estimate survival and retention in care and multiple logistic regression to investigate associations with individual-level factors.
Cryptococcal meningitis was diagnosed in 12.0% of the patients: 1066 at inclusion and 374 during follow-up. Incidence was 20.3 per 1000 person-years and decreased over time. At diagnosis, median age was 33 years, median CD4 cell count was 8 cells/μl, and 2.4% of patients were receiving combined antiretroviral therapy; 38.7% died and 34.6% were lost to follow-up. Of 750 patients alive and in care after 3 months of diagnosis, 85.9% received secondary cryptococcal meningitis prophylaxis and 13.7% relapsed in median 5.7 months [interquartile range 4.1-8.8] after cryptococcal meningitis diagnosis (relapse incidence=5.7 per 100 person-years; 95%CI 4.7-6.9). Cryptococcal meningitis was more common in men at programme entry (adjusted OR=2.24, 95% CI 1.67-3.00) and fell with higher levels of CD4 cell counts (P<0.0001).
Cryptococcal meningitis remains an important cause of morbidity and mortality in Cambodian HIV-infected patients. Our findings highlight the importance of increasing early access to HIV care and cryptococcal meningitis prophylaxis and of improving its diagnosis in resource-limited settings.
描述柬埔寨金边 Program 启动时 HIV 感染者中隐球菌病的诊断频率,研究相关的危险因素,并确定隐球菌性脑膜炎的发病率。
我们分析了 1999 年至 2008 年间入组的 11970 名 HIV 感染成人的个体监测数据。我们使用 Kaplan-Meier 初始方法估计生存和治疗保留率,并使用多因素逻辑回归分析个体因素的相关性。
12.0%的患者诊断为隐球菌性脑膜炎:1066 例在入组时诊断,374 例在随访期间诊断。发病率为 20.3/1000 人年,且随时间下降。诊断时,中位年龄为 33 岁,中位 CD4 细胞计数为 8 个/μl,2.4%的患者接受联合抗逆转录病毒治疗;38.7%的患者死亡,34.6%失访。在诊断后 3 个月时存活并在治疗中的 750 名患者中,85.9%接受了二线隐球菌性脑膜炎预防治疗,13.7%的患者在隐球菌性脑膜炎诊断后中位时间 5.7 个月(四分位距 4.1-8.8)复发(复发率为 5.7/100 人年;95%CI 4.7-6.9)。Program 启动时,男性中隐球菌性脑膜炎更常见(调整后的 OR=2.24,95%CI 1.67-3.00),随着 CD4 细胞计数的升高而下降(P<0.0001)。
在柬埔寨的 HIV 感染者中,隐球菌性脑膜炎仍然是发病率和死亡率的一个重要原因。我们的研究结果强调了在资源有限的情况下,增加 HIV 护理和隐球菌性脑膜炎预防治疗的早期获得机会以及改善其诊断的重要性。